BCL2 and hepatoblastoma: Another study has shown that Bcl-2 siRNA-mediated gene silencing increases the sensitivity of human hepatoblastoma HepG2 cells to chemotherapeutic drugs, including 5-fluorouracil and 10-hydroxycamptothecin.24